A novel partnership between MIT and Massachusetts General Hospital (MGH) is addressing three major challenges in clinical medicine: improving the diagnosis of disease; developing new approaches to prevent and treat infectious and autoimmune diseases; and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases. While individual…

Given a choice, most patients would prefer to take a drug orally instead of getting an injection. Unfortunately, many drugs, especially those made from large proteins, cannot be given as a pill because they get broken down in the stomach before they can be absorbed. To help overcome that obstacle,…

Today, the National Institutes of Health (NIH) announced their first round of BRAIN Initiative award recipients. Six teams and 15 researchers from the Massachusetts Institute of Technology were recipients. Mriganka Sur, principal investigator at the Picower Institute for Learning and Memory and the Paul E. Newton Professor of Neuroscience in…

Today, the National Institutes of Health (NIH) announced the first round of Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative award recipients, including several MIT interdisciplinary teams. The BRAIN Initiative, spearheaded by President Obama in April 2013, challenges the nation’s leading scientists to advance our sophisticated understanding of the human…

MIT engineers have devised a way to rapidly test hundreds of different drug-delivery vehicles in living animals, making it easier to discover promising new ways to deliver a class of drugs called biologics, which includes antibodies, peptides, RNA, and DNA, to human patients. In a study appearing in the journal…